Clinical trial · Observational
Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II
Improving Decision Making by Developing and Testing a Progressive Web App About Patient Decision Aid for Stage I-II Non-small Cell Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Studies indicate that the majority of early-stage non-small cell lung cancer (NSCLC) patients find it important to be involved in treatment decision making. However, in a recent study it has been reported that about 40% of the participants experienced decision conflict and feel uninformed(1). The investigators therefore developed a patient decision aid (PDA) for stage I-II NSCLC patients, that informs and empowers patients to help decide between stereotactic radiotherapy (SBRT) and surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Stage I | Malignant Lung Neoplasm | CURATED_BROADER | 0.78 |
| Lung Cancer Stage II | Malignant Lung Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient Decision Aid | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- IT specialist
- description
- 20 IT Specialist will evaluate the usability and patient-friendliness of the tool
- interventionNames
- Other: Patient Decision Aid
- label
- Doctors
- description
- 13 doctors will evaluate the information in the tool
- interventionNames
- Other: Patient Decision Aid
- label
- Patients
- description
- 10-20 patients will evaluate the utility and the contribution of the tool in decision making proces.
- interventionNames
- Other: Patient Decision Aid
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: Early stage non-small cell lung patients, Treated with curative intent minimum 6 month ago, max 5 years. Doctors IT Exclusion Criteria: Others
References
Publications (0)
Data not yet available